Douglas E. Feldman, PhD

Title(s)Assistant Professor of Research Pathology
Phone+1 323 442 3121
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Harvard College, Cambridge, MA. A.B. Magna cum laude Biochemistry
    Stanford University, Stanford, CA.Ph.DMolecular Cell Biology

    Collapse Overview 
    Collapse Overview
    Major Areas of Research Interest
    1. Our laboratory studies DNA base modifications and their erasure in the control of gene expression in stem cells and cancer. Our efforts extend to two distinct DNA modification systems: i) erasure of DNA cytosine methylation through Tet-oxidized 5-methylcytosine intermediates; and ii) DNA adenine N6- methylation (6mA), a previously unrecognized form of DNA modification in mammals. We are particularly interested in understanding how writers, sensors and erasers of these marks modulate gene control in embryonic stem cells, and how this process goes awry in cancers such as myeloid leukemia. We use a combination of protein biochemistry, mouse genetics and next-generation sequencing strategies (MeDIP-seq, RNA-seq, RRBS-seq) to address these questions.

    We also seek to uncover previously unknown regulators of DNA base modifications in human cells by interrogating bacterial and phage restriction- and counter-restriction associated genes through a bioinformatics pipeline to identify candidate human orthologs.

    2. Protein engineering and synthetic signaling pathways
    A major focus of our research is the design and construction of controllable, synthetic signaling systems. We apply the design principles of synthetic biology and directed evolution of native protein sensors of modified DNA bases to create controllable signaling modules with user-defined inputs and outputs. These engineered signaling modules are being tested in a range of cell-based therapeutic applications.

    Categories: Gene Control, Stem Cells, Cancer, Epigenetics, and DNA Methylation

    Collapse Research 
    Collapse Research Activities and Funding
    Engineering CAR-T for treatment of alcoholic liver disease
    NIH/NIAAA R21AA027535Sep 20, 2019 - Aug 31, 2021
    Role: Principal Investigator
    James H. Zumberge Faculty Research and Innovation Fund
    Robert E. and May R. Wright Foundation Trust
    American Cancer Society

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Shukla V, Halabelian L, Balagere S, Samaniego-Castruita D, Feldman DE, Arrowsmith CH, Rao A, Aravind L. HMCES Functions in the Alternative End-Joining Pathway of the DNA DSB Repair during Class Switch Recombination in B Cells. Mol Cell. 2019 Nov 15. PMID: 31806351.
      View in: PubMed
    2. Kweon SM, Chen Y, Moon E, Kvederaviciute K, Klimasauskas S, Feldman DE. An Adversarial DNA N6-Methyladenine-Sensor Network Preserves Polycomb Silencing. Mol Cell. 2019 Jun 20; 74(6):1138-1147.e6. PMID: 30982744.
      View in: PubMed
    3. Kweon SM, Zhu B, Chen Y, Aravind L, Xu SY, Feldman DE. Erasure of Tet-Oxidized 5-Methylcytosine by a SRAP Nuclease. Cell Rep. 2017 Oct 10; 21(2):482-494. PMID: 29020633.
      View in: PubMed
    4. Feldman DE, Chen C, Punj V, Machida K. The TBC1D15 oncoprotein controls stem cell self-renewal through destabilization of the Numb-p53 complex. PLoS One. 2013; 8(2):e57312. PMID: 23468968.
      View in: PubMed
    5. Feldman DE, Chen C, Punj V, Tsukamoto H, Machida K. Pluripotency factor-mediated expression of the leptin receptor (OB-R) links obesity to oncogenesis through tumor-initiating stem cells. Proc Natl Acad Sci U S A. 2012 Jan 17; 109(3):829-34. PMID: 22207628.
      View in: PubMed
    6. Feldman DE, Spiess C, Howard DE, Frydman J. Tumorigenic mutations in VHL disrupt folding in vivo by interfering with chaperonin binding. Mol Cell. 2003 Nov; 12(5):1213-24. PMID: 14636579.
      View in: PubMed